|
HY-N2459-5mg
|
MedChemexpress LLC
|
Peonidin (chloride) [CAS 134-01-0]
|
|
COVID-19-immunoregulation
|
|
|
HY-B2163-10mg
|
MedChemexpress LLC
|
Astaxanthin [CAS 472-61-7]
|
|
Cancer-programmed cell death
|
|
|
HY-B2163-5mg
|
MedChemexpress LLC
|
Astaxanthin [CAS 472-61-7]
|
|
Cancer-programmed cell death
|
|
|
HY-N1389-100mg
|
MedChemexpress LLC
|
Carmine [CAS 1390-65-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-N1389-500mg
|
MedChemexpress LLC
|
Carmine [CAS 1390-65-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-P73038A-10ug
|
MedChemexpress LLC
|
Erythropoietin/EPO, Mouse (HEK293)
|
|
|
|
|
HY-P73038A-100ug
|
MedChemexpress LLC
|
Erythropoietin/EPO, Mouse (HEK293)
|
|
|
|
|
HY-P73038A-2ug
|
MedChemexpress LLC
|
Erythropoietin/EPO, Mouse (HEK293)
|
|
|
|
|
HY-P73038A-50ug
|
MedChemexpress LLC
|
Erythropoietin/EPO, Mouse (HEK293)
|
|
|
|
|
HY-P73038A-500ug
|
MedChemexpress LLC
|
Erythropoietin/EPO, Mouse (HEK293)
|
|
|
|
|
HY-P73038-10ug
|
MedChemexpress LLC
|
Erythropoietin/EPO, Mouse (HEK293, solution)
|
|
|
|
|
HY-P73038-100ug
|
MedChemexpress LLC
|
Erythropoietin/EPO, Mouse (HEK293, solution)
|
|
|
|
|
HY-P73038-20ug
|
MedChemexpress LLC
|
Erythropoietin/EPO, Mouse (HEK293, solution)
|
|
|
|
|
HY-P73038-50ug
|
MedChemexpress LLC
|
Erythropoietin/EPO, Mouse (HEK293, solution)
|
|
|
|
|
HY-N2503-1mg
|
MedChemexpress LLC
|
Ginsenoside F4 [CAS 181225-33-2]
|
|
COVID-19-immunoregulation
|
|
|
HY-N2503-5mg
|
MedChemexpress LLC
|
Ginsenoside F4 [CAS 181225-33-2]
|
|
COVID-19-immunoregulation
|
|
|
HY-N0908-10mg
|
MedChemexpress LLC
|
Ginsenoside Rg5 [CAS 186763-78-0]
|
|
Cancer-Kinase/protease
|
|
|
HY-N0908-5mg
|
MedChemexpress LLC
|
Ginsenoside Rg5 [CAS 186763-78-0]
|
|
Cancer-Kinase/protease
|
|
|
HY-N0908-1mL
|
MedChemexpress LLC
|
Ginsenoside Rg5 [CAS 186763-78-0] (10mM in DMSO)
|
|
Cancer-Kinase/protease
|
|
